Analysts Have Conflicting Sentiments on These Healthcare Companies: Regeneron (REGN), BioMarin (BMRN) and Quidel Corp (QDEL)


Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (NASDAQ:REGN), BioMarin (NASDAQ:BMRN) and Quidel Corp (NASDAQ:QDEL).

Regeneron (REGN)

In a report released today, Geoff Meacham from Barclays maintained a Sell rating on Regeneron, with a price target of $305. The company’s shares closed on Friday at $394.88.

According to TipRanks.com, Meacham is a 4-star analyst with an average return of 5.3% and a 55.6% success rate. Meacham covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co Ltd, Achillion Pharmaceuticals, and United Therapeutics.

Regeneron has an analyst consensus of Hold, with a price target consensus of $388.92.

See today’s analyst top recommended stocks >>

BioMarin (BMRN)

Barclays analyst Gena Wang maintained a Hold rating on BioMarin today and set a price target of $98. The company’s shares closed on Friday at $99.47.

According to TipRanks.com, Wang is a 5-star analyst with an average return of 24.9% and a 53.0% success rate. Wang covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals Inc, Sarepta Therapeutics, and Mirati Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for BioMarin with a $118.50 average price target.

Quidel Corp (QDEL)

In a report released today, Jack Meehan from Barclays maintained a Buy rating on Quidel Corp, with a price target of $78. The company’s shares closed on Friday at $70.87, close to its 52-week high of $72.13.

According to TipRanks.com, Meehan is a 4-star analyst with an average return of 10.4% and a 65.3% success rate. Meehan covers the Healthcare sector, focusing on stocks such as Genomic Health, Thermo Fisher, and Icon plc.

Quidel Corp has an analyst consensus of Strong Buy, with a price target consensus of $73.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts